Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech republic;Rezistence k aminoglykozidům u nemocničních kmenů Acinetobacter baumannii v České republice

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 10, Issue 5, 2004, Pages 223-228

  Nemec, Alexandr ^a,b   Maixnerova M ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; NETILMICIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CZECH REPUBLIC; ENZYME MODIFICATION; GENETIC CODE; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACINETOBACTER BAUMANNII; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MEMBRANE TRANSPORT PROTEINS;

EID: 9244231839     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bergogne-Bérézin E, Towner K. Acinetobacter spp, as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148-165.
2. Bergogne-Bérézin E. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J Hosp Infect 1995;30:441-452.
3. Nemec A, Janda J, Melter O, Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech republic. J Med Microbiol 1999;48:287-296.
4. Turner PJ, Greenhalgh JM, MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 2003;9:563-567.
5. 21 and cecropin P1. Antimicrob Agents Chemother 2001;45:994-995.
6. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 1993;57:138-163.
7. Miller GH, Sabatelli FJ, Naples L, Hare RS, Shaw KJ. The most frequently occuring aminoglycoside mechanims - combined results of surveys in eight regions of the world. J Chemother 1995;7(Suppl 2):17-30.
8. Magnet S, Courvalin P, Lambert, T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii Strain BM4454. Antimicrob Agents Chemother 2001;45:3375-3380.
9. Vila J, Marcos A, Marco F, et al. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 1993;37:138-141.
10. Vila J, Ruiz J, Navia M, et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 1999; 37:758-761.
11. Seward RJ, Lambert T, Towner KJ. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J Med Microbiol 1998;47:455-462.
12. Dijkshoorn L, Aucken H, Gerner-Smidt P, et al. Comparison of outbreak and non-outbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996;34:1519-1525.
13. Nemec A, van der Reijden TJK, Dijkshoorn L. Multirezistentní klony Acinetobacter baumannii v Č eské republice. Klin Mikrobiol Inf Lék 2003;9:130-137.
14. Nemec A, Dijkshoorn L, van der Reijden TJK. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 2004;53:147-153.
15. van Dessel H, Dijkshoorn L, van der Reijden T, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004;155:105-112.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard, 7th ed. (document M2-A7). Wayne, PA: NCCLS, 2000.
17. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 6th ed. (document M7-A6). Wayne, PA: NCCLS, 2003.
18. Noppe-Leclercq I, Wallet F, Haentjens S, et al. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res Microbiol 1999;150:317-322.
19. Nemec A, Dijkshoorn L, Ježek P. Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens. J Clin Microbiol 2000;38:3937-3941.
20. Marchand I, Damier-Piolle L, Courvalin P, Lambert, T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the Ade-RS two-component system. Antimicrob Agents Chemother 2004;48:3298-3304.
21. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 2004;53:1233-1240.